The efficacy of lopinavir in individuals experiencing protease inhibitor failure

J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):238-40. doi: 10.1097/00126334-200302010-00018.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-HIV Agents / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • HIV Infections / therapy*
  • HIV Protease Inhibitors / therapeutic use
  • HIV-1*
  • Humans
  • Lopinavir
  • Male
  • Middle Aged
  • Protease Inhibitors / therapeutic use
  • Pyrimidinones / therapeutic use*
  • Ritonavir / therapeutic use*
  • Treatment Failure

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Protease Inhibitors
  • Pyrimidinones
  • Lopinavir
  • Ritonavir